(Q43672184)

25 November 2017

Synthesis and study of 5'-ester prodrugs of N6-cyclopentyladenosine, a selective A1 receptor agonist (English)

1 reference

25 November 2017

5

1 reference

25 November 2017

7

1 reference

25 November 2017

8

1 reference

25 November 2017

A Dalpiaz

1

1 reference

25 November 2017

A Scatturin

2

1 reference

25 November 2017

E Menegatti

3

1 reference

25 November 2017

F Bortolotti

4

1 reference

25 November 2017

C Biondi

6

1 reference

25 November 2017

1 April 2001

1 reference

25 November 2017

Pharmaceutical Research

1 reference

25 November 2017

18

1 reference

25 November 2017

4

1 reference

25 November 2017

531-536

1 reference

Processing of adenosine receptor agonists in rat and human whole blood

25 November 2017

1 reference

12 December 2020

Saturation assay for cyclic AMP using endogenous binding protein.

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic relationship of the cardiovascular effects of adenosine A1 receptor agonist N6-cyclopentyladenosine in the rat

1 reference

12 December 2020

Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors.

1 reference

12 December 2020

A threonine residue in the seventh transmembrane domain of the human A1 adenosine receptor mediates specific agonist binding

1 reference

12 December 2020

Cardiac electrophysiology and pharmacology of adenosine: basic and clinical aspects

1 reference

12 December 2020

Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning

1 reference

12 December 2020

Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists

1 reference

12 December 2020

Molecular cloning and characterisation of a human brain A1 adenosine receptor cDNA

1 reference

12 December 2020

Central versus peripheral mediation of responses to adenosine receptor agonists: evidence against a central mode of action

1 reference

12 December 2020

Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist

1 reference

12 December 2020

Novel therapeutics acting via purine receptors

1 reference

12 December 2020

Adenosine receptor prodrugs: synthesis and biological activity of derivatives of potent, A1-selective agonists

1 reference

12 December 2020

Nomenclature and classification of purinoceptors.

1 reference

12 December 2020

Enzymatic synthesis of 2'-O-acyl prodrugs of 1-(beta-D-arabinofuranosyl)-5(E)-(2-bromovinyl)uracil and of 2'-O-acyl-araU, -araC and -araA

1 reference

12 December 2020

Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1011018730459

1 reference

25 November 2017

1 reference